WallStreetZenWallStreetZen

NASDAQ: AMRN
Amarin Corp PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AMRN

Based on 1 analyst offering 12 month price targets for Amarin Corp PLC

Min Forecast
$12.00-20.21%
Avg Forecast
$12.00-20.21%
Max Forecast
$12.00-20.21%

Should I buy or sell AMRN stock?

Based on 1 analyst offering ratings for Amarin Corp PLC.

Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 100%
Although AMRN's forecast from analysts indicates a "Strong Sell", our proven Zen Rating quant model rates AMRN as a "Buy". Stocks with a Zen Rating of Buy have had an average return of +19.88% per year. Learn More

Be the first to know when Wall Street analysts revise their AMRN stock forecasts and price targets.

AMRN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-25

1 of 1

Forecast return on equity

Is AMRN forecast to generate an efficient return?

Company
-19.57%
Industry
-2,000.68%
Market
-51.7%
AMRN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMRN forecast to generate an efficient return on assets?

Company
-13.58%
Industry
22.8%
AMRN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMRN earnings per share forecast

What is AMRN's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$2.25
Avg 2 year Forecast
-$1.61
Avg 3 year Forecast
-$0.93

AMRN revenue forecast

What is AMRN's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$191.7M-12.59%
Avg 2 year Forecast
$174.2M-20.6%
Avg 3 year Forecast
$181.5M-17.25%
AMRN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMRN revenue growth forecast

How is AMRN forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
-6.84%
Industry
6.56%
Market
10.65%
AMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMRN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AMRN$15.04$12.00-20.21%Strong Sell
SCLX$17.76$630.00+3,447.30%Strong Buy
MIRA$1.37N/AN/A
OGN$9.42$14.00+48.62%Buy
GRFS$9.97$10.30+3.31%Hold
View Top General Drug Manufacturer Stocks

Amarin Stock Forecast FAQ

Is Amarin Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AMRN) stock is to Strong Sell AMRN stock.

Out of 1 analyst, 0 (0%) are recommending AMRN as a Strong Buy, 0 (0%) are recommending AMRN as a Buy, 0 (0%) are recommending AMRN as a Hold, 0 (0%) are recommending AMRN as a Sell, and 1 (100%) are recommending AMRN as a Strong Sell.

If you're new to stock investing, here's how to buy Amarin stock.

What is AMRN's earnings growth forecast for 2025-2027?

(NASDAQ: AMRN) Amarin's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 31.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.89%.

Amarin's earnings in 2025 is -$103,588,000.On average, 2 Wall Street analysts forecast AMRN's earnings for 2025 to be -$930,724,922, with the lowest AMRN earnings forecast at -$1,112,733,351, and the highest AMRN earnings forecast at -$748,716,493. On average, 3 Wall Street analysts forecast AMRN's earnings for 2026 to be -$664,620,326, with the lowest AMRN earnings forecast at -$843,857,263, and the highest AMRN earnings forecast at -$351,607,193.

In 2027, AMRN is forecast to generate -$384,699,635 in earnings, with the lowest earnings forecast at -$397,109,300 and the highest earnings forecast at -$376,426,524.

What is AMRN's revenue growth forecast for 2025-2027?

(NASDAQ: AMRN) Amarin's forecast annual revenue growth rate of -6.84% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.

Amarin's revenue in 2025 is $219,362,000.On average, 3 Wall Street analysts forecast AMRN's revenue for 2025 to be $79,316,791,530, with the lowest AMRN revenue forecast at $72,141,522,862, and the highest AMRN revenue forecast at $89,366,138,757. On average, 3 Wall Street analysts forecast AMRN's revenue for 2026 to be $72,051,759,614, with the lowest AMRN revenue forecast at $54,767,990,980, and the highest AMRN revenue forecast at $96,725,070,475.

In 2027, AMRN is forecast to generate $75,089,232,105 in revenue, with the lowest revenue forecast at $57,332,655,211 and the highest revenue forecast at $98,338,327,007.

What is AMRN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AMRN) forecast ROA is -13.58%, which is lower than the forecast US Drug Manufacturers - General industry average of 22.8%.

What is AMRN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AMRN price target, the average AMRN price target is $12.00, with the highest AMRN stock price forecast at $12.00 and the lowest AMRN stock price forecast at $12.00.

The Wall Street analyst predicted that Amarin's share price could fall to $12.00 by Jun 25, 2026. The average Amarin stock price prediction forecasts a potential downside of 20.21% from the current AMRN share price of $15.04.

What is AMRN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AMRN) Amarin's current Earnings Per Share (EPS) is -$5.00. On average, analysts forecast that AMRN's EPS will be -$2.25 for 2025, with the lowest EPS forecast at -$2.69, and the highest EPS forecast at -$1.81. On average, analysts forecast that AMRN's EPS will be -$1.61 for 2026, with the lowest EPS forecast at -$2.04, and the highest EPS forecast at -$0.85. In 2027, AMRN's EPS is forecast to hit -$0.93 (min: -$0.96, max: -$0.91).

What is AMRN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AMRN) forecast ROE is -19.57%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.